Perspectiva de los pacientes y variables económicas como objetivo en los ensayos clínicos, valores añadidos a los parámetros clínicos

The emergence of economic variables in clinical trials and phase IV observational studies evaluated was low, however, more than half of the revised protocols have included PRO measures, reflecting the importance of these parameters in the assessment of the effectiveness of drug treatments, although its use is still not systematic.